Brighton Jones LLC Invests $529,000 in Bath & Body Works, Inc. $BBWI

Brighton Jones LLC purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 17,664 shares of the company’s stock, valued at approximately $529,000.

Several other institutional investors also recently bought and sold shares of BBWI. Stonehage Fleming Financial Services Holdings Ltd purchased a new position in Bath & Body Works during the 2nd quarter worth $33,000. SVB Wealth LLC acquired a new position in shares of Bath & Body Works during the first quarter worth about $35,000. Geneos Wealth Management Inc. increased its stake in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC raised its holdings in Bath & Body Works by 63.3% during the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after purchasing an additional 481 shares in the last quarter. Finally, Golden State Wealth Management LLC lifted its position in Bath & Body Works by 94.7% in the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock valued at $40,000 after purchasing an additional 642 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Price Performance

NYSE BBWI opened at $24.82 on Thursday. The business has a 50 day moving average price of $27.26 and a 200 day moving average price of $29.03. The company has a market capitalization of $5.12 billion, a P/E ratio of 7.37, a PEG ratio of 0.90 and a beta of 1.52. Bath & Body Works, Inc. has a 1-year low of $24.81 and a 1-year high of $41.87.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts’ consensus estimates of $0.37. The company had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.Bath & Body Works’s quarterly revenue was down .8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works’s dividend payout ratio is presently 23.74%.

Wall Street Analyst Weigh In

BBWI has been the topic of several recent analyst reports. Jefferies Financial Group dropped their target price on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a research report on Monday, October 13th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $26.00 price target on shares of Bath & Body Works in a research note on Monday, October 6th. Wells Fargo & Company cut their price objective on Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a research report on Monday. Wall Street Zen downgraded Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, October 8th. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $36.39.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.